Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Creative Deal Structures Required: Insights from McDermott Will & Schulte’s Healthcare Private Equity Miami Conference
Building on our initial overview of McDermott Will & Schulte’s Healthcare Private Equity Miami conference, we are taking a deeper dive into the key panels and strategic dialogues that defined the event. It should be noted that the media at the conference were bound by the Chatham House Rule, so we will refer to speakers anonymously. A common theme that ran through multiple panels was that the 2026 market is drastically different from the market environment of previous years. While most experts offered an optimistic outlook for the remainder of 2026 and into 2027, others countered with a more cautious perspective given the market’s struggles over the past year. ... Read More »
Key Takeaways from HPE Miami 2026
LevinPro HC’s Kate Humphrey and Ben Swett attended McDermott Will & Schulte’s Healthcare Private Equity Miami conference, which brought together healthcare leaders in a powerhouse summit on the sands of South Beach. For two days, industry experts and leaders moved beyond surface-level buzz and delved into the complexities of private equity in healthcare. Attendees engaged in conversations ranging from investors’ latest stance on AI to analyzing the hottest investment sectors. Here are our top takeaways: New Normal for Dealmaking A large portion of the conversations centered on a “new normal” for dealmaking, in which the market has shifted from the post-pandemic frenzy to a more... Read More »
February Freeze: Healthcare M&A Cools
Following a robust start in January, healthcare M&A volume declined notably in February. With 144 announced transactions, the deal volume for February 2026 is 40% lower than the 240 reported in January 2026, but marks a small decrease from the 150 announced in February 2025. Despite the decline in M&A volume, it is worth noting that February is historically a quiet month for deal activity and is following the trend; over the last five years, there has been an average of 150 deals reported throughout February. As with most months, most transactions were in the Physician Medical Group (PMG) sector, with 33 deals, accounting for 23% of activity. This is a 42% drop from the 57 PMG... Read More »
Beyond the Deal Volume: A Conversation With CEO Doug Drew of USOSM
Driven by a highly fragmented market landscape and sustained patient demand for care, the dental industry has emerged as an appealing sector for strategic consolidation and acquisition opportunities in the past five years. According to data captured in the LevinPro HC M&A database, the dental industry represents 48% of the Physician Medical Group sector’s activity, with 219 transactions announced since the start of 2025. Formed in 2017 and backed by Oak Hill Capital Partners, U.S. Oral Surgery Management (USOSM) has crafted a reputation as a dominating force in the dental space. With a presence in more than 30 states, USOSM provides operational, financial and administrative support... Read More »
October Deal Volume Dips 17% as Market Pressures Mount
The last few months have been a relentless storm of reimbursement and market changes. Far from finding calm, October has seen new challenges that have that power to impact healthcare M&A and deal activity. With substantial economic and regulatory pressures, healthcare M&A activity in October declined, but remained steady overall. According to data captured in the LevinPro HC database on November 3, preliminary numbers indicate that there was a 17% drop in deal volume from September (195 transactions) to October 2025 (162 transactions). It is worth noting that September 2025’s high deal activity is more of an outlier; October’s activity was more consistent with the... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
